Advertisement

Topics

The Dawn of a New Era: Transforming our Domestic Response to Hepatitis B & C Company Profile

21:02 EST 10th December 2018 | BioPortfolio


News Articles [1220 Associated News Articles listed on BioPortfolio]

Effectiveness of chronic hepatitis C treatment using direct-acting antivirals: real-life data

Hepatitis is an inflammation of the liver and can be caused by medications, toxins, severe alcohol use and other medical conditions. Hepatitis can also be caused by viruses, most commonly hepatitis A,...

Impact of SVR on Risk of T2DM Among HCV Patients in the US

Does achieving sustained virologic response lower the risk for development of type 2 diabetes mellitus in patients with hepatitis C? Journal of Viral Hepatitis

Liver-Fibrosis Regression Seen After Hepatitis C Cure

Liver fibrosis regresses in some patients with chronic hepatitis C infection who achieve a sustained virological response (SVR) to oral direct-acting antivirals (DAA), according to a retrospective stu...

World Hepatitis Day 2018: Fighting the hepatitis menace – Times of India

Times of IndiaWorld Hepatitis Day 2018: Fighting the hepatitis menaceTimes of IndiaLiver is one of the most important organs in our body. Apart from its role in digestion, it has many other vital func...

A Grossly Inadequate Global Response to Chronic Hepatitis B Virus Infection

Only 1.5% of all individuals in the world with chronic hepatitis B virus infection are receiving treatment.

World Hepatitis Day: Nearly 1.76 cr Indians infected with deadly virus; building awareness can help reduce risk – Firstpost

FirstpostWorld Hepatitis Day: Nearly 1.76 cr Indians infected with deadly virus; building awareness can help reduce riskFirstpostEditor's Note: According to the World Hepatitis Alliance, globally arou...

World Hepatitis Day 2018: 89% of people with hepatitis are unaware

The World Hepatitis Alliance’s (WHA) global campaign for World Hepatitis Day 2018 on 28 July and the next three years...Read More... The post World Hepatitis Day 2018: 89% of people with hepatitis a...

Simple Blood Test Devised for Hepatitis B

Viral hepatitis is a major global health problem, and estimates suggest that hepatitis B was responsible for about half of...

Drugs and Medications [46 Associated Drugs and Medications listed on BioPortfolio]

Dawn [Procter & Gamble Manufacturing Company]

Dawn Ultra Concentrated Extra Action AB

Dawn [Procter & Gamble Manufacturing Company]

Dawn Ultra Concentrated plus Power Scrubber Orange AB

Dawn [Procter & Gamble Manufacturing Company]

Dawn Ultra Concentrated plus Power Scrubber Apple Blossom AB

Dawn [Procter & Gamble Manufacturing Company]

Dawn Ultra Concentrated Apple Blossom AB

Dawn [Procter & Gamble Manufacturing Company]

Dawn Ultra Concentrated Orange AB

PubMed Articles [2518 Associated PubMed Articles listed on BioPortfolio]

Pretreatment Hepatitis B Viral Load Predicts Long-term Hepatitis B Response after Anti-hepatitis C Therapy in Hepatitis B/C Dual-infected Patients.

We aimed to investigate the long-term outcomes in hepatitis B (HBV)/hepatitis C (HCV) dual-infected patients after anti-HCV therapy.

Daily activity patterns of movement and refuge use in Triatoma gerstaeckeri and Rhodnius prolixus (Hemiptera: Reduviidae), vectors of the Chagas disease parasite.

Transmission risk for vector borne disease is greatest during periods of heightened vector activity. Triatomine bugs (Hemiptera: Reduviidae), which transmit Trypanosoma cruzi, the causative agent of C...

A case of incidental infection of Hepatitis E virus (HEV) genotype 1 in a domestic pig.

Hepatitis E virus (HEV) infection involving zoonotic genotypes is a public health problem in high-income and non-endemic developing countries. Herein we report the detection of a human genotype 1 (HEV...

Inappropriate response against Hepatitis B vaccine in health personnel of the National Hospital, Paraguay.

health personnel are a risk group for acquiring hepatitis B. The vaccine against it is effective but requires evaluation of the immune response with the dosage of anti-HBs.

Hepatitis C: is eradication possible?

Hepatitis C has a relevant global impact in terms of morbidity, mortality and economic costs, with more than 70 million people infected worldwide. In the resolution "Transforming our world: the 2030 A...

Clinical Trials [4639 Associated Clinical Trials listed on BioPortfolio]

Evaluation of Domestic Hemodialysis Machine: A Multi-center Clinical Study

An important reason for the costs of hemodialysis treatment in China are expensive is the hemodialysis machine and related products mainly rely on imports. Hemodialysis machine is the basi...

Comparison of Lantus and Neutral Protamine Hagedorn (NPH) Insulin in the Dawn Phenomenon

1. To investigate the effect of insulin glargine (Lantus™) vs NPH insulin regarding glycemic control during the early AM (dawn phenomenon) in individuals with type 1 diabetes. ...

Immune Response to Hepatitis C Virus

The purpose of the study is to investigate the immune response to hepatitis C virus to determine why some people clear the virus and others develop chronic infection. Changes in immune re...

Effectiveness and Side Effects of Pegylated Interferon Alpha-2a (Pegaferon®) Plus Ribavirin in the Patients With Chronic Hepatitis C

Pegylation of interferon prolongs the medication half-life which has resulted in Pegylated Interferon (PEG-IFN) as the new modality for treatment of chronic hepatitis C. We current this cl...

Immunologic Response of Hepatitis B Vaccine

This study aims to evaluate the immunologic response to the two hepatitis B virus (HBV) vaccination booster strategies in previously vaccinated HIV-infected adults at Maharaj Nakorn Chiang...

Companies [987 Associated Companies listed on BioPortfolio]

The Dawn of a New Era: Transforming our Domestic Response to Hepatitis B & C

Hepatitis B Foundation

The Hepatitis B Foundation is the only national nonprofit organization solely dedicated to finding a cure and improving the quality of life for those affected with hepatitis B worldwide through resear...

World Hepatitis Alliance

The following people have provided quotes expressing their support to the World Hepatitis Alliance campaign for a WHO resolution on viral hepatitis. For further information please contact worldhep...

iQur Ltd

iQur® is a specialty pharmaceutical company at the forefront of international breakthroughs in the detection, treatment and monitoring of Hepatitis C and other liver diseases.iQur exists to provide c...

National Domestic Violence Hotline

The National Domestic Violence Hotline was established in 1996 as a component of the Violence Against Women Act (VAWA) passed by Congress and is supported by funding from the U.S. Department of Health...

More Information about "The Dawn of a New Era: Transforming our Domestic Response to Hepatitis B & C" on BioPortfolio

We have published hundreds of The Dawn of a New Era: Transforming our Domestic Response to Hepatitis B & C news stories on BioPortfolio along with dozens of The Dawn of a New Era: Transforming our Domestic Response to Hepatitis B & C Clinical Trials and PubMed Articles about The Dawn of a New Era: Transforming our Domestic Response to Hepatitis B & C for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of The Dawn of a New Era: Transforming our Domestic Response to Hepatitis B & C Companies in our database. You can also find out about relevant The Dawn of a New Era: Transforming our Domestic Response to Hepatitis B & C Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record